The stock of Biolife Solutions Inc (NASDAQ: BLFS) has decreased by -10.20 when compared to last closing price of 24.11. Despite this, the company has experienced a -17.18% fall in its stock price over the last five trading sessions. prnewswire.com reported 2024-11-14 that Completes the Company’s strategic move away from capital equipment businesses BOTHELL, Wash., Nov. 14, 2024 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the sale of its final wholly owned freezer subsidiary, Arctic Solutions, Inc. (“Custom Biogenic Systems” or “CBS”), for $6.1 million in cash.
Is It Worth Investing in Biolife Solutions Inc (NASDAQ: BLFS) Right Now?
Moreover, the 36-month beta value for BLFS is 1.88. Analysts have varying opinions on the stock, with 8 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for BLFS is 44.93M and currently, short sellers hold a 7.79% of that float. On November 15, 2024, BLFS’s average trading volume was 326.73K shares.
BLFS’s Market Performance
The stock of Biolife Solutions Inc (BLFS) has seen a -17.18% decrease in the past week, with a -5.66% drop in the past month, and a -16.25% fall in the past quarter. The volatility ratio for the week is 9.72%, and the volatility levels for the past 30 days are at 5.64% for BLFS. The simple moving average for the past 20 days is -10.17% for BLFS’s stock, with a 2.29% simple moving average for the past 200 days.
Analysts’ Opinion of BLFS
Many brokerage firms have already submitted their reports for BLFS stocks, with H.C. Wainwright repeating the rating for BLFS by listing it as a “Buy.” The predicted price for BLFS in the upcoming period, according to H.C. Wainwright is $29 based on the research report published on September 30, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see BLFS reach a price target of $22. The rating they have provided for BLFS stocks is “Buy” according to the report published on April 04th, 2024.
Craig Hallum gave a rating of “Buy” to BLFS, setting the target price at $29 in the report published on July 11th of the previous year.
BLFS Trading at -9.99% from the 50-Day Moving Average
After a stumble in the market that brought BLFS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.03% of loss for the given period.
Volatility was left at 5.64%, however, over the last 30 days, the volatility rate increased by 9.72%, as shares sank -6.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.45% lower at present.
During the last 5 trading sessions, BLFS fell by -17.18%, which changed the moving average for the period of 200-days by +27.35% in comparison to the 20-day moving average, which settled at $24.10. In addition, Biolife Solutions Inc saw 33.23% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BLFS starting from Berard Todd, who sale 91 shares at the price of $26.34 back on Nov 12 ’24. After this action, Berard Todd now owns 107,756 shares of Biolife Solutions Inc, valued at $2,397 using the latest closing price.
Foster Karen A., the Chief Quality and Operations of Biolife Solutions Inc, sale 66 shares at $26.34 during a trade that took place back on Nov 12 ’24, which means that Foster Karen A. is holding 157,225 shares at $1,738 based on the most recent closing price.
Stock Fundamentals for BLFS
Current profitability levels for the company are sitting at:
- -0.23 for the present operating margin
- 0.46 for the gross margin
The net margin for Biolife Solutions Inc stands at -0.37. The total capital return value is set at -0.08. Equity return is now at value -9.87, with -8.19 for asset returns.
Based on Biolife Solutions Inc (BLFS), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -34.6.
Currently, EBITDA for the company is -45.24 million with net debt to EBITDA at -0.63. When we switch over and look at the enterprise to sales, we see a ratio of 8.22. The receivables turnover for the company is 6.88for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.78.
Conclusion
To wrap up, the performance of Biolife Solutions Inc (BLFS) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
